Thomas Höfner

2.4k total citations · 1 hit paper
51 papers, 1.4k citations indexed

About

Thomas Höfner is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Thomas Höfner has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 24 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Thomas Höfner's work include Bladder and Urothelial Cancer Treatments (21 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Prostate Cancer Treatment and Research (13 papers). Thomas Höfner is often cited by papers focused on Bladder and Urothelial Cancer Treatments (21 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Prostate Cancer Treatment and Research (13 papers). Thomas Höfner collaborates with scholars based in Germany, Austria and Canada. Thomas Höfner's co-authors include Andreas Trumpp, Martin R. Sprick, Corinna Klein, Vanessa Vogel, Irène Baccelli, Anja Schillert, Wilko Weichert, Tobias Bäuerle, Andreas Schneeweiß and Tim Holland‐Letz and has published in prestigious journals such as Nature Biotechnology, The Journal of Urology and European Urology.

In The Last Decade

Thomas Höfner

48 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

2013 836 citations Irène Baccelli, Andreas Schneeweiß et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Höfner Germany	13	854	478	367	321	208	51	1.4k
Lisle M. Nabell United States	23	726 0.9×	213 0.4×	487 1.3×	603 1.9×	248 1.2×	57	1.9k
Keith D. Amos United States	17	1.1k 1.3×	575 1.2×	127 0.3×	494 1.5×	124 0.6×	32	1.9k
Anton Scharl Germany	20	644 0.8×	438 0.9×	277 0.8×	248 0.8×	59 0.3×	127	1.5k
Cecelia E. Schmalbach United States	18	561 0.7×	104 0.2×	211 0.6×	275 0.9×	267 1.3×	68	1.6k
Bethany L. Niell United States	22	660 0.8×	500 1.0×	331 0.9×	130 0.4×	66 0.3×	62	1.8k
Amol Narang United States	21	1.2k 1.4×	365 0.8×	705 1.9×	136 0.4×	79 0.4×	140	2.1k
Jacob E. Shabason United States	17	383 0.4×	334 0.7×	355 1.0×	652 2.0×	67 0.3×	45	1.3k
Assuntina G. Sacco United States	23	787 0.9×	286 0.6×	588 1.6×	329 1.0×	95 0.5×	60	1.8k
S. David Nathanson United States	19	642 0.8×	344 0.7×	159 0.4×	235 0.7×	118 0.6×	41	1.2k
Drew Moghanaki United States	21	687 0.8×	199 0.4×	1.3k 3.4×	283 0.9×	69 0.3×	118	2.2k

Countries citing papers authored by Thomas Höfner

Since Specialization

Citations

This map shows the geographic impact of Thomas Höfner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Höfner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Höfner more than expected).

Fields of papers citing papers by Thomas Höfner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Höfner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Höfner. The network helps show where Thomas Höfner may publish in the future.

Co-authorship network of co-authors of Thomas Höfner

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Höfner. A scholar is included among the top collaborators of Thomas Höfner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Höfner. Thomas Höfner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mercier, Dominique, et al.. (2025). Development of an artificial intelligence-generated, explainable treatment recommendation system for urothelial carcinoma and renal cell carcinoma to support multidisciplinary cancer conferences. European Journal of Cancer. 220. 115367–115367. 1 indexed citations

Wagner, Isabel, René Mager, Thomas Höfner, et al.. (2024). Temporal Trends in Urinary Diversion among Patients Undergoing Radical Cystectomy Between 1986 and 2022: Experience at the University Medical Center Mainz with 2224 Cases. Annals of Surgical Oncology. 31(10). 7220–7228. 1 indexed citations

Wagner, Isabel, René Mager, Christopher Neumann, et al.. (2024). Radical cystectomy in patients aged < 80 years versus ≥ 80 years: analysis of preoperative geriatric assessment scores in predicting postoperative morbidity and mortality. World Journal of Urology. 42(1). 552–552. 1 indexed citations

Böehm, Katharina, Christian Ruckes, Robert Dotzauer, et al.. (2024). Individualized center-based analysis of urinary and sexual functional outcome after radical prostatectomy based on the prostate cancer outcome study: a post hoc pathway to patient outcome measurement analysis for quality improvement. World Journal of Urology. 42(1). 236–236. 2 indexed citations

Höfner, Thomas, et al.. (2023). Solitary cardiac metastasis of urothelial carcinoma of the urinary bladder with squamous cell differentiation – a rare manifestation. Urology Case Reports. 46. 102318–102318.

Böehm, Katharina, Hendrik Borgmann, Thomas Ebert, et al.. (2021). Stage and Grade Migration in Prostate Cancer Treated With Radical Prostatectomy in a Large German Multicenter Cohort. Clinical Genitourinary Cancer. 19(2). 162–166.e1. 11 indexed citations

Hardenberg, Jost von, Angelika Borkowetz, Fabian Siegel, et al.. (2020). Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging–targeted Biopsy: A Large Multicenter Cohort Study. European Urology Focus. 7(5). 1002–1010. 10 indexed citations

Wenzel, Mike, Hendrik Borgmann, Jost von Hardenberg, et al.. (2020). Acceptance, Indications and Chances of Focal Therapy in Localized Prostate Cancer: A Real-World Perspective of Urologists in Germany. Journal of Endourology. 35(4). 444–450. 3 indexed citations

Kamal, Mohamed M., Hendrik Borgmann, Wilco de Jager, et al.. (2020). The PT2D-Score: a novel tool to predict complications and economic outcome after radical cystectomy. World Journal of Urology. 38(12). 3155–3160. 1 indexed citations

10.

Böehm, Katharina, Maximilian Peter Brandt, Anita Thomas, et al.. (2020). Telemedicine Online Visits in Urology During the COVID-19 Pandemic—Potential, Risk Factors, and Patients’ Perspective. European Urology. 78(1). 16–20. 146 indexed citations

11.

Mager, René, Katharina Böhm, Anita Thomas, et al.. (2019). Comparative assessment of docetaxel for safety and efficacy between hormone-sensitive and castration-resistant metastatic prostate cancer. Urologic Oncology Seminars and Original Investigations. 37(12). 999–1005. 6 indexed citations

12.

Brandt, Maximilian Peter, Christian A. Thomas, Igor Tsaur, et al.. (2019). Immune check point inhibitors for metastatic urothelial carcinoma: current evidence-based approach for urology daily practice. Minerva Urologica e Nefrologica. 71(3). 205–216. 1 indexed citations

13.

Mager, René, M. Kurosch, Thomas Höfner, et al.. (2018). Clinical outcomes and costs of reusable and single-use flexible ureterorenoscopes: a prospective cohort study. Urolithiasis. 46(6). 587–593. 58 indexed citations

14.

Höfner, Thomas, Christian Eisen, Corinna Klein, et al.. (2015). Defined Conditions for the Isolation and Expansion of Basal Prostate Progenitor Cells of Mouse and Human Origin. Stem Cell Reports. 4(3). 503–518. 24 indexed citations

15.

Höfner, Thomas, Sonia Vallet, Boris Hadaschik, et al.. (2014). Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort. World Journal of Urology. 33(6). 833–839. 4 indexed citations

16.

Vallet, Sonia, Sascha Pahernik, Thomas Höfner, et al.. (2014). Efficacy of Targeted Treatment Beyond Third-Line Therapy in Metastatic Kidney Cancer: Retrospective Analysis From a Large-Volume Cancer Center. Clinical Genitourinary Cancer. 13(3). e145–e152. 16 indexed citations

17.

Höfner, Thomas, Stephan Macher‐Goeppinger, Corinna Klein, et al.. (2014). Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy. Urologic Oncology Seminars and Original Investigations. 32(5). 678–686. 36 indexed citations

18.

Baccelli, Irène, Andreas Schneeweiß, Sabine Riethdorf, et al.. (2013). Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nature Biotechnology. 31(6). 539–544. 836 indexed citations breakdown →

19.

May, Matthias, Patrick J. Bastian, Maximilian Burger, et al.. (2011). Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder. British Journal of Urology. 108(8b). E278–83. 15 indexed citations

20.

Höfner, Thomas, Jesco Pfitzenmaier, Sascha Pahernik, et al.. (2010). PSA density lower cutoff value as a tool to exclude pathologic upstaging in initially diagnosed unilateral prostate cancer: impact on hemiablative focal therapy. World Journal of Urology. 30(1). 91–95. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact